98538350
May 7, 2024
Pharmaceutical preparations, namely, IVIG (Intravenous Immunoglobulin); immune globulin and hyperimmune globulin for pharmaceutical purposes; immune globulin and hyperimmune globulin preparations for the treatment of primary and secondary immunodeficiencies; immune globulin and hyperimmune globulin preparations for the prevention or treatment of infectious diseases; hyperimmune globulin preparation for the prevention or treatment of hepatitis B
Pharmaceuticals